Abbott Laboratories sold $14.7 billion of bonds yesterday in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.
Abbott issued bonds in six parts through its AbbVie Inc. pharmaceutical unit, ranging in size from $500 million to $4 billion, according to data compiled by Bloomberg. Proceeds will help fund a $7.7 billion tender offer related to AbbVie’s spinoff.
